Two independent studies add even* more support to $ACRV
Two studies published this week add support for $ACRV’s drug ACR-368(prexasertib) Study 1: CAF-1 / chromatin assembly + prexasertib study: https://www.biorxiv.org/content/10.64898/2026.09.27.754407v1 Study looked into CHK1 inhibition in cancer cells with defective chromatin assembly. Study shows that treatment with prexasertib let …